Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0BU5K
|
||||
| Former ID |
DNC013882
|
||||
| Drug Name |
TINGENIN B
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [526834] | ||
| Formula |
C28H36O4
|
||||
| Canonical SMILES |
CC1CC2C(CCC3(C2(CCC4(C3=CC=C5C4=CC(=O)C(=C5C)O)C)C)C)(C<br />(C1=O)O)C
|
||||
| InChI |
1S/C28H36O4/c1-15-13-21-26(4,24(32)22(15)30)10-12-27(5)20-8-7-17-16(2)23(31)19(29)14-18(17)25(20,3)9-11-28(21,27)6/h7-8,14-15,21,24,31-32H,9-13H2,1-6H3/t15-,21-,24-,25+,26-,27-,28+/m1/s1
|
||||
| InChIKey |
QIRUFAFQGKOTKA-ZRWKYKNNSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Aldose reductase | Target Info | Inhibitor | [526834] | |
| NetPath Pathway | IL1 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||